His keynote speech at ACMS focused on artificial intelligence for precision medicine and cancer diagnosis.
Jordan Bui and Bernard A. Cohen, MD, review a case of a young patient with vitiligo.
David Rosmarin, MD, shared his insights on the study in a Q&A with Dermatology Times.
Bradley Burnam discusses results from an in-vivo model of atopic dermatitis.
Earlier this summer, Meghan Heberton, MD, emphasized the importance and growth of the subspecialty.
Nearly 44.2% of patients achieved HiSCR100, indicating a complete resolution of HS symptoms by the end of the 2-year period.
Experts in the field share why they enjoyed the 5th Annual Revolutionizing Atopic Dermatitis Conference and why it is unique.
John Browning, MD, FAAD, FAAP, MBA, discusses the new online platform that allows young patients to share their skin journey with others.
Mickey Bryson describes the impact of atopic dermatitis on his quality of life and family, and the session concludes with final reflections.
Pharmacists play a role in advising patients with hair loss about self-management and proper application of over the counter products.
Explore how BCs are supported through complex drug approvals and ensuring patients have access to prescribed medications.
Cheryl Burgess, MD, will share pearls on counseling patients on appropriate cosmetic procedures for their skin type, safety measures, and strategies to achieve desired outcomes.
It is crucial to better understand, diagnose, and manage this skin condition associated with significant quality-of-life impairment.
Understanding the difference in biology and clinical presentations of cutaneous conditions in different skin types is critical for health care professionals to treat a diverse population.
Graber discusses isotretinoin dosing and monitoring pearls at SCALE 2023.
Sonya Kenkare, MD, explains her approach to itch and the support system of multiple specialties to help a pediatric patient with atopic dermatitis.
Frequent fliers, including pilots and cabin crew, are exposed to greater levels of UV and cosmic ionizing radiation than the general population, leading to higher incidence of skin cancers.
In the final part of this Frontline Forum series, Brent Moody, MD; Sarah Arron, MD, PhD; Justine Cohen, DO; Emily Ruiz, MD, MPH; and Todd Schlesinger, MD, review 4 real-world clinical cases of BCC and the treatments they utilized.
Second-line end points of the TRICOTEL trial assessing atezolizumab plus vemurafenib and cobimetinib in melanoma with central nervous system metastases appear consistent with primary efficacy end points.
A variety of topicals and biologics are now available to treat children affected by this challenging condition.
It is important for pediatric and family nurse practitioners caring for patients with dermatological conditions to be comfortable talking about the conditions with children, adolescents, and their parents.
Frequent fliers, including pilots and cabin crew, are exposed to greater levels of UV and cosmic ionizing radiation than the general population, leading to higher incidence of skin cancers.